Date updated:06-09-2007
From Barron's 6-11-07:
Each week Barrons has a 13D Filings column. 13Ds are filed when a fund (usually an activist hedge fund) accumulates more than 5% of a firm and is planning on pushing for change (e.g.a sale of the company, sale of certain assets, a share buyback, or a share dividend) to unlock value.

-
BLG
Blg - $0.00
- N/A
- $N/A
From Barron's 6-11-07 Hedge-fund manager Robert Chapman sent a letter to the company requesting a meeting with top management. Chapman said that he'd like to discuss Building Materials' expense-reduction and capital-allocation plans. Chapman also reiterated his request that Building Materials hire an investment adviser to explore the sale of the company. Chapman Capital reported ownership of 2.4 million shares (8.1% of the total outstanding).

-
ESST
Ess Technology - $0.00
- 0.00%
- $N/A
From Barron's 6-11-07 Riley Investment Management said that the company should shut its operations, sell its assets and return the proceeds to shareholders. Riley Investment contends that this would generate proceeds of $2.70 a share and warned that, otherwise, the company has "little or no prospect of turning a profit in the foreseeable future." Riley Investment asserts that the management of ESS faces an "uphill battle" in restoring profitability to the company, citing intense competition and what it termed a declining outlook for ESS' core DVD-chip products. Riley Investment owns 6.7% of the shares outstanding.

-
PVFC
Pvf Capital Corp. - $2.194
- +9.70%
- $2.34
From Barron's 6-11-07 Investor Umberto P. Fedeli submitted a proposal asking the company to declassify its board structure. Fedeli said that he would buy 1.5 million to two million shares if he were allowed to control three board seats and if the company shook up its management and altered its strategic business plan. The company hasn't issued an official response to Fedeli's offer. The declassification proposal would require that all PVF directors be elected each year, instead of having only a few directors up for annual election. Fedeli currently holds 465,000 shares (6%).

-
INXI
Inx Inc. - $5.25
- +18.24%
- $4.44
From Barron's 6-11-07 Doucet Capital reported ownership of 348,279 shares (5.3%) after buying 6,845 from May 4 to 30 at prices ranging from $9.25 to $10.98. INX provides Internet protocol communications services and products.

-
EYE
Advanced Med Opti - $7.87
- +14.06%
- $7.03
From Barron's 6-11-07 A group including ValueAct Capital Management raised its stake to 5.9 million shares (9.9%) from the 4.4 million (7.3%) reported on May 1. Advanced Medical Optics makes eye-care and ophthalmologic devices

-
RTRSY
2.47 - $74.40
- 0.00
- $74.40
From Barron's 6-11-07 ValueAct Capital Management raised its holdings to 96.4 million shares (7.7%) from the 83.55 million (6.5%) that it reported on Feb. 21.

-
HALO
Halozyme Therapeu - $6.29
- +0.64%
- $6.30
From Barron's 6-11-07 Halozyme director Randal J. Kirk increased his stake to 11.04 million shares (14.6%) from the 7.5 million (10.5%) that he reported on May 24. Halozyme is a biopharmaceutcial company based in San Diego.
- Barron's Activist Stocks 6-11-07's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Charlie Munger
- 2. Bernard L. Madoff Inve...
- 3. Renaissance Technologies
- 4. Templeton World A (TEMWX)
- 5. Fidelity Select Consum...
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » HMH1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » 10 Short Squeezes
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- show all
Investors were spooked on Wednesday as bleak broad-based corporate outlooks and dismal employment data dominated headlines. Stocks experienced their largest drop in more t...
At Stockpickr.com, we strive to keep track of insider purchasing and buybacks each week. Here's the perfect setup in my mind: insiders buying the stock, the company buying ...
The traders of CNBC’s "Fast Money" think the current stock market is a traders' market. In order to play a traders' market, you have to nimble. You also have to know whic...
Pfizer (PFE) CEO Jeff Kindler has hinted that the world’s biggest drugmaker is open to a large-scale acquisition. “The real goal is to grow revenues," he told the Fina...
A. do yourself a big favor and read cramers
books first. no one should be in the
market without some knowledge of how it
works. also, the market may well be over
valued. no one knows. finally, if you
just have to ignore this advice, stay
way away from 2x or 3x etf's. good luck,
mike
A. small trading before thrusday
Analyst Upgrades for Jan. 5, 2009 more
This list consists of stocks that have had very nice up move over the last year and may be poised to disappoint going forward. The basis for the list is as follows: 52 w... more
This portfolio consists of NYSE stocks that are trading for less than $5 per share and are profitable. more






Comments not available